Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pollard

Showing results (621-630 of 992) with videos related to

Pageof 100
Sort By:
The Journal of Infectious Diseases|September 15, 2021
A Systematic Review and Meta-analysis of Animal Studies Investigating the Relationship Between Serum Antibody, T Lymphocytes, and Respiratory Syncytial Virus DiseaseJoseph McGinley, Ryan Thwaites, Will Brebner, et al.
The Journal of Clinical Investigation|April 22, 2020
Ebola virus glycoprotein stimulates IL-18-dependent natural killer cell responsesHelen R Wagstaffe, Elizabeth A Clutterbuck, Viki Bockstal, et al.
The Pediatric Infectious Disease Journal|May 8, 2024
The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory StudyAlexander Maytum, David Porter, Philip de Whalley, et al.
BMJ Open|October 30, 2015
Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adultsC A Green, E Scarselli, M Voysey, et al.
Vaccine|December 15, 2024
Predictors of severity of SARS-CoV-2 infections in Brazil: Post hoc analyses of a randomised controlled trialKerry Conlin, Daniel Jenkin, Philip de Whalley, et al.
Journal of Immunology Research|June 12, 2019
OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable VaccinesNicola Cotugno, Alessandra Ruggiero, Veronica Santilli, et al.
Clinical Science (London, England : 1979)|June 1, 1997
Hypoxia, hypocapnia and spirometry at altitudeA J Pollard, P W Barry, N P Mason, et al.
Science (New York, N.Y.)|December 9, 1988
Neonatal hepatitis induced by alpha 1-antitrypsin: a transgenic mouse modelM J Dycaico, S G Grant, K Felts, et al.
The Pediatric Infectious Disease Journal|June 16, 2011
Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccinePhilip C S de Whalley, Matthew D Snape, Dominic F Kelly, et al.
Frontiers in Immunology|March 18, 2017
Importance of <i>Salmonella</i> Typhi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge ModelStephanie Fresnay, Monica A McArthur, Laurence S Magder, et al.
Pageof 100

Showing results (621-630 of 992) with videos related to

Sort By:
Pageof 100
The Journal of Infectious Diseases|September 15, 2021
A Systematic Review and Meta-analysis of Animal Studies Investigating the Relationship Between Serum Antibody, T Lymphocytes, and Respiratory Syncytial Virus DiseaseJoseph McGinley, Ryan Thwaites, Will Brebner, et al.
The Journal of Clinical Investigation|April 22, 2020
Ebola virus glycoprotein stimulates IL-18-dependent natural killer cell responsesHelen R Wagstaffe, Elizabeth A Clutterbuck, Viki Bockstal, et al.
The Pediatric Infectious Disease Journal|May 8, 2024
The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory StudyAlexander Maytum, David Porter, Philip de Whalley, et al.
BMJ Open|October 30, 2015
Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adultsC A Green, E Scarselli, M Voysey, et al.
Vaccine|December 15, 2024
Predictors of severity of SARS-CoV-2 infections in Brazil: Post hoc analyses of a randomised controlled trialKerry Conlin, Daniel Jenkin, Philip de Whalley, et al.
Journal of Immunology Research|June 12, 2019
OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable VaccinesNicola Cotugno, Alessandra Ruggiero, Veronica Santilli, et al.
Clinical Science (London, England : 1979)|June 1, 1997
Hypoxia, hypocapnia and spirometry at altitudeA J Pollard, P W Barry, N P Mason, et al.
Science (New York, N.Y.)|December 9, 1988
Neonatal hepatitis induced by alpha 1-antitrypsin: a transgenic mouse modelM J Dycaico, S G Grant, K Felts, et al.
The Pediatric Infectious Disease Journal|June 16, 2011
Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccinePhilip C S de Whalley, Matthew D Snape, Dominic F Kelly, et al.
Frontiers in Immunology|March 18, 2017
Importance of <i>Salmonella</i> Typhi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge ModelStephanie Fresnay, Monica A McArthur, Laurence S Magder, et al.
Pageof 100